1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment patterns after abiraterone acetate in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of COU-AA-302
    Meeting Abstract

    Flaig, T. W.; Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; Kheoh, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Integrated genomic correlates of response to PD-1 inhibitor nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    de Velasco, G.; Miao, D.; Shukla, S.; Voss, M. H.; Wu, C.; Murray, B.; Meyerson, M.; Signoretti, S.; Motzer, R. J.; Van Allen, E. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L. P.; Kowalyszyn, R. D.; Karyakin, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L. P.; Kowalyszyn, R. D.; Karyakin, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Investigation of a frequently mutated transcriptional repressor in prostate cancer, in particular its role in modulating androgen signaling and its effects on TMPRSS2-ERG dependent tumor maintenance
    Meeting Abstract

    Bose, R.; Abida, W.; Iaquinta, P.; Karthaus, W.; Armenia, J.; Wongvipat, J.; Doran, M.; Hieronymus, H.; Philip, W.; Liang, Y. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Surrogacy analysis of prostate-specific antigen (PSA) decline for improved overall survival (OS) with enzalutamide (ENZ) in AFFIRM
    Meeting Abstract

    Armstrong, A. J.; Saad, F.; Shore, N. D.; Fizazi, K.; Phung, D.; Dmuchowski, C. F.; Hirmand, M.; Forer, D.; Scher, H. I.; De Bono, J. S.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Garcia, J. A.; Alva, A. S.; Hart, L. L.; Milowsky, M. I.; Posadas, E. M.; Ryan, C. J.; Summa, J. M.; Youssoufian, H.; Scher, H. I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save